Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05089877 · ClinicalTrials.gov registry record
FREEZE-AFIB Post-Market Study
A clinical trial of Atrial Fibrillation and Atrial Flutter, sponsored by AtriCure.
- Completed
- Registry status
- 39
- Enrollment target
- 6
- Study locations
NCT05089877 is a study of Atrial Fibrillation and Atrial Flutter that has completed, run by AtriCure. The registered enrollment target is 39 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT05089877, a study of Atrial Fibrillation and Atrial Flutter, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study is proposed herein is to gather clinical data on the safety and performance of the CRYOF device.
Conditions Studied
Interventions
- DEVICE Surgical Ablation
Study Locations (6)
Connecticut
- Hartford Hospital - Hartford
- Yale University School of Medicine - New Haven
Illinois
- Northwestern University - Evanston
Michigan
- University of Michigan - Ann Arbor
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Tennessee
- Saint Thomas West Hospital - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2022-04-29 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05089877
The ClinicalTrials.gov registry entry for NCT05089877 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Surgical Ablation is the first listed.
NCT05089877 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Connecticut, Illinois, Michigan.
Frequently Asked Questions
What is clinical trial NCT05089877 about?
NCT05089877 is a clinical study titled "FREEZE-AFIB Post-Market Study". This study is proposed herein is to gather clinical data on the safety and performance of the CRYOF device.
What is the current status of trial NCT05089877?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2022-04-29. Estimated completion is 2023-12-31.
What conditions does trial NCT05089877 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Atrial Flutter.
What interventions are being tested in trial NCT05089877?
The interventions under investigation include: Surgical Ablation (DEVICE).
Who is sponsoring clinical trial NCT05089877?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05089877 being conducted?
This trial has 6 study locations across Connecticut, Illinois, Michigan, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.